Skip to content
Wenlo
Sign in
← Markets

Candel Therapeutics, Inc.

Candel Therapeutics, Inc. (CADL) — Form 424B5: Prospectus

424B5CADLFiled Nov 12, 2026, 11:22 AM ET

About this filing

Candel Therapeutics, Inc. (CADL) filed Form 424B5 (prospectus) with the SEC on Nov 12, 2026.

Key facts

Document
424B5

More CADL filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.